Description
Human KRAS (2-185, G12D) Protein, His Tag (active enzyme, MALS verified) | KRS-H51H4-1mg| Gentaur Distribution US, UK & Europe
KRAS (Kirsten rat sarcoma 2 viral oncogene homolog) gene is a proto-oncogene that encodes a small GTPase transductor protein called KRAS. KRAS is also known as Ki-Ras, c-K-ras and c-Ki-ras. Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Plays an important role in the regulation of cell proliferation, promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner. RAS is one of the most frequently mutated oncogenes in human cancer but the frequency and distribution of RAS gene mutations are not uniform. In details, mutation of glycine 12 (G12) causes RAS activation by interfering with GAP binding and GAP-stimulated GTP hydrolysis. The reference shows the pathway may as a potential therapy targets.
Source: Human KRAS (2-185, G12D), His Tag (KRS-H51H4) is expressed from E. coli cells. It contains AA Thr 2 - Cys 185 (Accession # P01116-2 (G12D) ).
Format: Powder.
Tag: N-10×His.
Expression System: E. coli.
Expression Region: Thr 2 - Cys 185.
Conjugate: Unconjugated.
Molecular Weight: 23.0 kDa.
Characteristics: This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 23.0 kDa. The protein migrates as 25-27 kDa under reducing (R) condition (SDS-PAGE).
Purity: 95%.
Buffer: 50mM Tris, 500mM NaCl pH7.3.
Storage Conditions: -20℃.
Shipping Conditions: RT
